Stay updated on CLEAR Trial: Lenvatinib Combos vs Sunitinib in RCC
Sign up to get notified when there's something new on the CLEAR Trial: Lenvatinib Combos vs Sunitinib in RCC page.

Latest updates to the CLEAR Trial: Lenvatinib Combos vs Sunitinib in RCC page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe ClinicalTrials.gov record for the CLEAR phase 3 study of lenvatinib-based combinations versus sunitinib is displayed, including study details, participant criteria, outcomes, locations, publications, and study documents.SummaryDifference100%

- Check18 days agoChange DetectedThe site footer now identifies the release as v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check32 days agoChange DetectedA sitewide NIH announcement about updated terminology appears above the ClinicalTrials.gov 403 error page. The displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check46 days agoChange DetectedThe footer revision label advances from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check60 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study details, indicating blocked access to the record. This represents an error-state page rather than a substantive content update.SummaryDifference17%

- Check67 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, indicating a routine backend update. There are no changes to the study content or user-facing information reflected in the provided data.SummaryDifference0.0%

Stay in the know with updates to CLEAR Trial: Lenvatinib Combos vs Sunitinib in RCC
Enter your email address, and we'll notify you when there's something new on the CLEAR Trial: Lenvatinib Combos vs Sunitinib in RCC page.